Olanzapine plus venlafaxine in treatment-resistant depression

Chehil S , Devarajan S , Dursun S M (2000) Pharmacological strategies for refractory depression . Can Family Physician 47: 50-52

Cowen P J (1996) Advances in psychopharmacology: mood disorder and dementia . Br Med Bull 52: 539-555

Dursun S M , Devarajan S (2001) Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms . Psychopharmacol 153: 497-498

Dursun S M , Devarajan S , Kutcher S (2001) The Dalhousie Serotonin Cocktail for treatment resistant depressive disorder . J Psychopharmacol 152: 136-138

Matthews J D , Bottonane K A , Polania L M , Mischonlon D , Derding C M , Iroin R , Fava M (2002) An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses . J Clin Psychiatry 63: 1164-1170

Morris J S , Smith K A , Cowen P J , Friston K J , Dolan R J (1999) Covariation of activity in habenula and dorsal raphe nuclei following tryptophan depletion . Neuroimage 10: 163-172

Sharpley A L , Vassallo C M , Cowen P J (2000) Olanzapine increases slow-wave sleep: evidence for blockade of central 2C receptors in vivo . Biol Psychiatry 47: 468-470

Sharpley A L , Vassallo C M , Pooley E C , Harrison P J , Cowen P J (2001) Allelic variation in the 5HT2C receptor and the increase in slow wave sleep produced by olanzapine . Psychopharm 153: 271-272

Shelton R C , Tollefson G D , Tohen M , Stahl S , Gannon K S , Jacobs T G , Buras W R , Bymaster F P , Zhang W , Spencer K A , Feldman P D , Meltzer H Y (2001) A novel augmentation strategy for treating resistant major depression . Am J Psychiatry 158: 131-134

Zhang W , Perry K W , Wong D T , Potts B D , Bao J , Tollefson G P , Bymaster F D (2000) Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex . Neuropsychopharmacology 23: 250-262